Mri Scan
DUET topline data: Terns’ THR-beta agonist drastically reduced liver fat content in NASH
Topline findings from the phase 2a DUET trial showed that Tern Pharmaceuticals’ oral thyroid hormone receptor-beta agonist achieved significant reductions in liver fat content among patients with nonalcoholic steatohepatitis.
Mucus plugs revealed via imaging correlate with airflow obstruction, eosinophilia
WASHINGTON — Providers can measure mucus plugs directly with computer tomography and indirectly with MRI imaging, according to data presented at the American Thoracic Society International Conference.
Arlington, twist tests may be more sensitive, specific in diagnosing hip labral tears
Results showed the Arlington test may be more sensitive and the twist test may be more specific in diagnosing hip labral tears compared with the traditional flexion-adduction-internal rotation/impingement test.
Advances in MRI, PET imaging crucial to improve diagnosis, prognosis of MS
SAN DIEGO — Advances in the ability to measure chronic, active inflammation in MS using MRI and positron emission tomography may improve disease diagnosis and prognosis, according to research presented at ACTRIMS 2023.
Open wedge high tibial osteotomy linked with patellofemoral joint degeneration
According to published results, open wedge high tibial osteotomy with a small correction angle may be associated with degeneration of articular cartilage within the patellofemoral joint.
Oligomerix launches phase 1a trial for tau self-association inhibitor for Alzheimer’s
Dosing has begun in participants enrolled in a phase 1a clinical trial of OLX-07010, an oral small molecule inhibitor of tau self-association for Alzheimer’s disease, manufacturer Oligomerix announced in a press release.
FDA approves hyperpolarized MRI contrast agent for evaluating lung ventilation
The FDA has approved xenon Xe 129 hyperpolarized, or Xenoview, to use along with MRI to analyze lung ventilation among adults and children aged 12 years and older, according to a manufacturer-issued press release.
MRI-directed targeted biopsy reduced prostate cancer overdiagnosis
Compared with systematic biopsy, MRI-directed targeted biopsy reduces the risk of overdiagnosis of prostate cancer for men with elevated prostate-specific antigen levels, according to researchers.
Pancreatic cancer screening yields moderate benefit, ‘no harms’ for high-risk patients
CHARLOTTE, N.C. — Pancreatic cancer screenings in high-risk individuals identified high-risk lesions in nearly 1% of patients and intermediate-risk pathology in more than 30%, according to data presented at the ACG Annual Scientific Meeting.
Nearly one-third of patients with spine disease asymptomatic at CRMO diagnosis
PHILADELPHIA — Nearly half of patients with spine disease reported no back pain at CRMO onset, and one-third were asymptomatic despite active lesions on whole body MRI at diagnosis, according to data presented at ACR Convergence 2022.